Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
2
3
4
5
6
7
8
9
10
11
-7.3%
2.1%
-2.7%
-3.2%
1.0%
11.5%
5.7%
5.8%
12
0%
%) TTB
%) TTB
%) TTB
13
-21.1% 31.4%
0.9% 25.3%
-19.1% 107.8%
-1.9% 25.0%
-25.6% -28.0%
35.9% 39.5%
-18.8% 8.3%
-15.0% 0%
14
15
16
17
18
LAPSInsulin Combo HM14220
Diabetes
SANOFI
GMB Stem Cell Therapy HM21001
Glioblastoma
AJOU Univ LAPSTriple Agonist
HM15211
Obesity
LAPSGCG Analog HM15136
Congenital Hyperinsulinism
LAPSlDS HM15410
Mucopoysaccharidosis
FLT3 Inhibitor HM43239
AML
PD-1/HER-2 BH2950
Breast, Gastric cancer
B
PD-1/PD-L1 BH2941
Cancer
B LAPSGLP-2 Analog
HM15410
Short Bowel Syndrome
Pre-Clinical Phase 2 Phase 3 Phase 1
LAPSGLP/GCG HM12525A
Diabetes/Obesity
JANSSEN
LAPSInuslin HM12470
Diabetes
Pan-RAF Inhibitor HM95573
Solid tumor
GENENTECH
Oratecan™ Irinotecan+HM30181A
Solid tumor
ATHENEX
Src/Tubulin KX2-391
Solid tumor
ATHENEX
PD-1/EGFR BH2922
NSCLC, Colorectal cancer
B
LAPSExd4 Analog Efpeglenatide
Diabetes/Obesity
SANOFI
LAPShGH Efpegsomatropin
GH deficiency
Olita® * Olmutinib
NSCLC
ZAI LAB
Luminate®
Integrin inhibitor
DME
ALLEGRO
BTK Inhibitor HM71224
Autoimmune diseases
ELI LILLY
Pan-HER Inhibitor Poziotinib
Solid tumor
SPECTRUM/LUYE
Rolontis™ Eflapegrastim Neutropenia
SPECTRUM
Oraxol™** Paclitaxel+HM30181A
Breast cancer
ATHENEX
Diabetes/Obesity
Rare Diseases
Cancer
Autoimmune Diseases
Others
B Beijing Hanmi
19